Yarrow Bioscience, Inc. cotiza a 19.82 USD y tiene una capitalización bursátil de $184M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disea…
| Métrica | YARW | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -5219.1% | -38.6% | -5180.5% |
| Net Margin | -4646.1% | -33.6% | -4612.6% |
| FCF Margin | -5811.2% | -13.9% | -5797.4% |
| ROE | -95.4% | -40.4% | -55.0% |
| ROA | -87.8% | -32.0% | -55.8% |
| Current Ratio | 12.53 | 2.84 | +9.69 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |